To the Editor: In a recent issue of Blood, Guenechea et al[1][1]reported that ex vivo cytokine-expanded CD34+ cord blood cells retained nonobese diabetic/severe combined immunodeficient (NOD/SCID) repopulating activity of fresh cells, although there was a significant delay in the time to achieve
No takes yet. Share an insight, caveat, or question.
Blundell et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: